POLE mutations as an alternative pathway for microsatellite instability in endometrial cancer: Implications for Lynch syndrome testing

Cancer

Volumn 121, Issue 3, 2015, Pages 331-334

  Konstantinopoulos, Panagiotis A ^a   Matulonis, Ursula A ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED DNA POLYMERASE DELTA; DNA DIRECTED DNA POLYMERASE EPSILON; DNA DIRECTED DNA POLYMERASE ALPHA; POLE PROTEIN, HUMAN;

AMINO ACID SUBSTITUTION; CANCER CLASSIFICATION; COPY NUMBER VARIATION; DNA METHYLATION; DNA REPLICATION; EDITORIAL; ENDOMETRIUM CANCER; EXONUCLEASE DOMAIN MUTATION; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOMICS; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HETEROZYGOSITY LOSS; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUTATION RATE; OVERALL SURVIVAL; PHENOTYPE; POLD1 GENE; POLE GENE; POLYMERASE CHAIN REACTION; PROGRESSION FREE SURVIVAL; PROMOTER REGION; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM TUMOR; FEMALE; GENETICS; MISSENSE MUTATION;

CARCINOMA, ENDOMETRIOID; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA POLYMERASE II; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MUTATION, MISSENSE;

EID: 84921517577     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29057     Document Type: Editorial

References (11)

1. Cancer Genome Atlas Research Network, Kandoth C, Schultz N, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497:67-73.
2. Nick McElhinny SA, Gordenin DA, Stith CM, Burgers PM, Kunkel TA. Division of labor at the eukaryotic replication fork. Mol Cell. 2008;30:137-144.
3. Henninger EE, Pursell ZF. DNA polymerase epsilon and its roles in genome stability. IUBMB Life. 2014;66:339-351.
4. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330-337.
5. Briggs S, Tomlinson I. Germline and somatic polymerase epsilon and delta mutations define a new class of hypermutated colorectal and endometrial cancers. J Pathol. 2013;230:148-153.
6. Albertson TM, Ogawa M, Bugni JM, et al. DNA polymerase epsilon and delta proofreading suppress discrete mutator and cancer phenotypes in mice. Proc Natl Acad Sci U S A. 2009;106:17101-17104.
7. Billingsley CC, Cohn DE, Mutch DG, Stephens JA, Suarez AA, Goodfellow PJ. Polymerase E (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing. Cancer. 2015;121:386-394.
8. Zhao S, Choi M, Overton JD, et al. Landscape of somatic singlenucleotide and copy-number mutations in uterine serous carcinoma. Proc Natl Acad Sci U S A. 2013;110:2916-2921.
9. Carethers JM. Differentiating Lynch-like from Lynch syndrome. Gastroenterology. 2014;146:602-604.
10. Bruegl AS, Djordjevic B, Batte B, et al. Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer. Cancer Prev Res (Phila). 2014;7:686-697.
11. Moline J, Mahdi H, Yang B, et al. Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center. Gynecol Oncol. 2013;130:121-126.